Prognosis of weight reduction by thyroid functio
Not Applicable
- Conditions
- obesity
- Registration Number
- JPRN-UMIN000016718
- Lead Sponsor
- ational Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1.Autoimmune thyroid disease patients undergoing treatment. 2.Patients under thyroid hormone (Levothyroxine) supplementation. 3.Patients being administered medicine which affects thyroid function, such as interferon. 4.Patients whom the chief physician determines are not applicable for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum TSH, free T4, free T3, body weight (before and after six-month weight reduction regime), body fat composition (visceral fat)
- Secondary Outcome Measures
Name Time Method BMI,blood pressure,CAVI,total blood cell count,TP,Alb,T-Bil,D-Bil,AST,ALT,Gamma-GTP, BUN, Cr, Na, K, Cl, Ca, P, HbA1c, BS, IRI, T-Chol, HDL-C, LDL-C, TG, hsCRP, adiponectin, leptin